Jasper Therapeutics (JSPR)
NASDAQ:JSPR
JSPR Analyst Ratings
Moderate Buy
3 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
JSPR Stock 12 Month Forecast
Average Price Target
$9.90
▲(1334.78% Upside)
| Highest Price Target$20.00 | Average Price Target$9.90 | Lowest Price Target$1.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
UBS
$1.5
Hold
117.39%
Upside
Reiterated
04/02/26
Evercore ISI
$12→$7
Buy
914.49%
Upside
Reiterated
04/01/26
William Blair
―
Hold
―
Reiterated
03/31/26
RBC Capital
$4
Hold
479.71%
Upside
Reiterated
03/30/26
H.C. Wainwright
$20
Buy
2798.55%
Upside
Assigned
03/30/26
Rodman & Renshaw
$17
Buy
2363.77%
Upside
Initiated
01/13/26
BTIG
$7
Buy
914.49%
Upside
Reiterated
12/02/25
TD Cowen
―
Buy
―
Reiterated
11/10/25
Citizens JMP
$12→$6
Buy
769.57%
Upside
Reiterated
09/22/25
Cantor Fitzgerald
―
Hold
―
Downgraded
07/07/25
Oppenheimer
$65
Buy
9320.29%
Upside
Reiterated
06/16/25
Truist Financial
$48→$46
Buy
6566.67%
Upside
Reiterated
05/12/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
UBS
$1.5
Hold
117.39%
Upside
Reiterated
04/02/26
Evercore ISI
$12→$7
Buy
914.49%
Upside
Reiterated
04/01/26
William Blair
―
Hold
―
Reiterated
03/31/26
RBC Capital
$4
Hold
479.71%
Upside
Reiterated
03/30/26
H.C. Wainwright
$20
Buy
2798.55%
Upside
Assigned
03/30/26
Rodman & Renshaw
$17
Buy
2363.77%
Upside
Initiated
01/13/26
BTIG
$7
Buy
914.49%
Upside
Reiterated
12/02/25
TD Cowen
―
Buy
―
Reiterated
11/10/25
Citizens JMP
$12→$6
Buy
769.57%
Upside
Reiterated
09/22/25
Cantor Fitzgerald
―
Hold
―
Downgraded
07/07/25
Oppenheimer
$65
Buy
9320.29%
Upside
Reiterated
06/16/25
Truist Financial
$48→$46
Buy
6566.67%
Upside
Reiterated
05/12/25
Best Analysts Covering Jasper Therapeutics
3 Months
xxx
Success Rate
6/15 ratings generated profit
Average Return
+2.83%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of +2.83% per trade.
1 Year
2 Years
xxx
Success Rate
1/15 ratings generated profit
Average Return
-65.64%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 6.67% of your transactions generating a profit, with an average return of -65.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
JSPR Analyst Recommendation Trends
Rating
Sep 25
Nov 25
Dec 25
Jan 26
Mar 26
Strong Buy
13
9
8
7
6
Buy
2
2
1
1
0
Hold
7
5
6
16
21
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
22
16
15
25
28
Each month's total comprises the sum of three months' worth of ratings.
JSPR Financial Forecast
JSPR Stock Forecast FAQ
What is JSPR’s average 12-month price target, according to analysts?
Based on analyst ratings, Jasper Therapeutics’s 12-month average price target is 9.90.
What is JSPR’s upside potential, based on the analysts’ average price target?
Jasper Therapeutics has 1334.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is JSPR a Buy, Sell or Hold?
Jasper Therapeutics has a consensus rating of Moderate Buy which is based on 3 buy ratings, 3 hold ratings and 0 sell ratings.
What is Jasper Therapeutics’s price target?
The average price target for Jasper Therapeutics is 9.90. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $1.50. The average price target represents 1334.78% Increase from the current price of $0.69.
The highest analyst price target is $20.00 ,the lowest forecast is $1.50. The average price target represents 1334.78% Increase from the current price of $0.69.
What do analysts say about Jasper Therapeutics?
Jasper Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of JSPR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.